Literature DB >> 33908452

Multifunctional hybrid sponge for in situ postoperative management to inhibit tumor recurrence.

Haixia Wang1, Yuanyuan Jin1, Yanyan Chen1, Yun Luo2, Shixian Lv3, Mingqiang Li1, Yu Tao4.   

Abstract

Disseminated tumor cells in bleeding and residual tumor cells in the resection tumor site are the primary factors that result in tumor recurrence after surgery. Safe and efficient local implantation of the drug depot system into the resection cavity to inhibit tumor recurrence would be of great benefit to reduce the mortality of postoperative patients. Here, a sandwich-like doxorubicin-triptolide-loaded fiber/(chitosan/gelatin) sponge, DTF/CGS, is fabricated, combining hemostatic, antibacterial, and chemotherapeutic capability. The CGS obtained via freeze-drying can efficiently prevent bleeding; meanwhile, the metastatic residual tumor cells are stuck with the clotted absorbed blood. Subsequently, dual drugs released from the electrospun fiber can further kill the stuck tumor cells in CGS and the disseminated tumor cells to significantly inhibit the tumor recurrence. This antitumor recurrence strategy by immediately implanting a multifunctional hybrid sponge for in situ postoperative management may possess great potential for preventing tumor recurrence.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33908452     DOI: 10.1039/d1bm00085c

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  2 in total

1.  3D printed hydrogel scaffolds combining glutathione depletion-induced ferroptosis and photothermia-augmented chemodynamic therapy for efficiently inhibiting postoperative tumor recurrence.

Authors:  Wentao Dang; Wei-Chih Chen; Enguo Ju; Yanteng Xu; Kai Li; Haixia Wang; Kun Wang; Shixian Lv; Dan Shao; Yu Tao; Mingqiang Li
Journal:  J Nanobiotechnology       Date:  2022-06-07       Impact factor: 9.429

Review 2.  Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma.

Authors:  Huimin Kong; Enguo Ju; Ke Yi; Weiguo Xu; Yeh-Hsing Lao; Du Cheng; Qi Zhang; Yu Tao; Mingqiang Li; Jianxun Ding
Journal:  Adv Sci (Weinh)       Date:  2021-10-19       Impact factor: 16.806

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.